Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Veradermics, Inc Director's Dealing 2026

Feb 6, 2026

51537_dirs_2026-02-05_3da51438-ef76-4720-a616-f5d60042b762.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Veradermics, Inc (MANE)
CIK: 0001827635
Period of Report: 2026-02-03

Reporting Person: Coric Vlad (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-05 Common Stock C 33706 Acquired 33706 Indirect
2026-02-05 Common Stock C 33706 Acquired 33706 Indirect
2026-02-05 Common Stock C 148794 Acquired 182500 Indirect
2026-02-05 Common Stock C 148794 Acquired 182500 Indirect
2026-02-05 Common Stock C 78075 Acquired 260575 Indirect
2026-02-05 Common Stock C 78075 Acquired 260575 Indirect
2026-02-05 Common Stock C 117112 Acquired 129939 Direct
2026-02-05 Common Stock P 58823 $17 Acquired 319398 Indirect
2026-02-05 Common Stock P 58823 $17 Acquired 319398 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-05 Series A Convertible Preferred Stock $ C 33706 Disposed Common Stock (33706) Indirect
2026-02-05 Series A Convertible Preferred Stock $ C 33706 Disposed Common Stock (33706) Indirect
2026-02-05 Series B Convertible Preferred Stock $ C 148794 Disposed Common Stock (148794) Indirect
2026-02-05 Series B Convertible Preferred Stock $ C 148794 Disposed Common Stock (148794) Indirect
2026-02-05 Series C Convertible Preferred Stock $ C 78075 Disposed Common Stock (78075) Indirect
2026-02-05 Series C Convertible Preferred Stock $ C 78075 Disposed Common Stock (78075) Indirect
2026-02-05 Series C Convertible Preferred Stock $ C 117112 Disposed Common Stock (117112) Direct
2026-02-03 Stock Option (Right to Buy) $17 A 51525 Acquired 2036-02-03 Common Stock (51525) Direct

Footnotes

F1: On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F2: Shares held by Vladimir Coric Family Trust 2013.

F3: Shares held by Vladimir Coric Marital Trust 2013.

F4: On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F5: On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F6: This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.